iconstar paper   HIV Articles  
Back grey arrow rt.gif
Repatha Lipodystrophy
  Download the PDF here
Download the PDF here
Download the PDF here
I have received a HIV+ patient communication directly from the patient who reports a 90-95% reversal of facial lipoatrophy & increased rear end fat, he had never had belly fat so nothing to report on that, this is after treatment with Repatha, the PCKS9 inhibitor from Amgen. I have communicated with the research medical team at amgen & the lead investigator of the just enrolling HIV Repatha study but its too late to look at this in their study.
Jules Levin
Here is the Descartes Repatha study which I think provides some insights into the metabolic affects of Repatha & here also is FDA Review. And the Spplementary Appendix which reports breakdown in more detail of metabolic changes.

  iconpaperstack View Older Articles   Back to Top   www.natap.org